• Home
  • Team
  • Blog
  • Experts
  • Careers
  • Projects
  • Code of Conduct
  • Press
  • Publications
  • Contact Us

Hematology

Gynecologic Cancers   

Questions discussed in this category


How do you counsel patients who are candidates for a clinical trial regarding their options?
Specifically, are there strategies you use to 1) empower patients to participate in decision-making and 2) reassure patients who may be skeptical?
1 Answer available

Do you routinely prophylactically anticoagulate patients undergoing systemic chemotherapy outside of the perioperative period?
1 Answer available
90118323


Papers discussed in this category


Blood, 2008-05-15
Development and validation of a predictive model for chemotherapy-associated thrombosis.

The New England journal of medicine, 2019-02-21
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

J Thromb Haemost, 2019 Jul 28
The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.

N Engl J Med, 2018 Dec 04
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

Related Topics in Hematology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Cancers
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2021 theMednet
All Rights Reserved.